Efficacy of thalidomide in the treatment of VAD-refractory plasma cell leukaemia appearing after autologous stem cell transplantation for multiple myeloma

被引：14
作者：
Bauduer, F [1 ]
机构：
[1] Ctr Hosp Cote Basque, Hematol Serv, Bayonne, France
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2002年 / 117卷 / 04期
关键词：
thalidomide; plasma cell leukaemia; multiple myeloma;
D O I：
10.1046/j.1365-2141.2002.03537_4.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：996 / 997
页数：2
相关论文
共 5 条
  • [1] Thalidomide in multiple myeloma:: lack of response of soft-tissue plasmacytomas
    Bladé, J
    Perales, M
    Rosiñol, L
    Tuset, M
    Montoto, S
    Esteve, O
    Cobo, F
    Villela, L
    Rafel, M
    Nomdedeu, B
    Montserrat, E
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2001, 113 (02) : 422 - 424
  • [2] PRIMARY PLASMA-CELL LEUKEMIA
    DIMOPOULOS, MA
    PALUMBO, A
    DELASALLE, KB
    ALEXANIAN, R
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1994, 88 (04) : 754 - 759
  • [3] Thalidomide and its analogs overcome drug resistance of human multiple myeloma cells to conventional therapy
    Hideshima, T
    Chauhan, D
    Shima, Y
    Raje, N
    Davies, FE
    Tai, YT
    Treon, SP
    Lin, B
    Schlossman, RL
    Richardson, P
    Muller, G
    Stirling, DI
    Anderson, KC
    [J]. BLOOD, 2000, 96 (09) : 2943 - 2950
  • [4] Frequent good partial remissions from thalidomide including best response ever in patients with advanced refractory and relapsed myeloma
    Juliusson, G
    Celsing, F
    Turesson, I
    Lenhoff, S
    Adriansson, M
    Malm, C
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2000, 109 (01) : 89 - 96
  • [5] Antitumor activity of thalidomide in refractory multiple myeloma.
    Singhal, S
    Mehta, J
    Desikan, R
    Ayers, D
    Roberson, P
    Eddlemon, P
    Munshi, N
    Anaissie, E
    Wilson, C
    Dhodapkar, M
    Zeldis, J
    Barlogie, B
    Siegel, D
    Crowley, J
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (21) : 1565 - 1571
1